Neurizon Therapeutics (FRA:ECQ0) ROE % Adjusted to Book Value : -21.37% (As of Dec. 2024)

Neurizon Therapeutics ROE % Adjusted to Book Value Chart

Neurizon Therapeutics Annual Data
	Trend	Jun15	Jun16	Jun17	Jun18	Jun19	Jun20	Jun21	Jun22	Jun23	Jun24
ROE % Adjusted to Book Value		Get a 7-Day Free Trial					-3.29	-5.56	-7.86	-19.64	-17.37

Neurizon Therapeutics Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-0.24	-40.69	-2.67	-26.40	-21.37

Competitive Comparison of Neurizon Therapeutics's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Neurizon Therapeutics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neurizon Therapeutics's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neurizon Therapeutics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Neurizon Therapeutics's ROE % Adjusted to Book Value falls into.

Neurizon Therapeutics ROE % Adjusted to Book Value Calculation

Neurizon Therapeutics's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2024 is calculated as

Neurizon Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neurizon Therapeutics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Neurizon Therapeutics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurizon Therapeutics Business Description